| “BRCAness” syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and … DSP Tan, C Rothermundt, K Thomas, E Bancroft, R Eeles, S Shanley, ... Journal of Clinical Oncology 26 (34), 5530-5536, 2008 | 561 | 2008 |
| Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised … B Seddon, SJ Strauss, J Whelan, M Leahy, PJ Woll, F Cowie, ... The lancet oncology 18 (10), 1397-1410, 2017 | 408 | 2017 |
| Phase 2 trial of single-agent everolimus in chemotherapy-naive patients with castration-resistant prostate cancer (SAKK 08/08) AJ Templeton, V Dutoit, R Cathomas, C Rothermundt, D Bärtschi, ... European urology 64 (1), 150-158, 2013 | 142 | 2013 |
| Prevalence and risk factors of hepatitis B and C virus infections in an impoverished urban community in Dhaka, Bangladesh H Ashraf, NH Alam, C Rothermundt, A Brooks, P Bardhan, L Hossain, ... BMC infectious diseases 10, 1-8, 2010 | 140 | 2010 |
| Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09) C Rothermundt, S Hayoz, AJ Templeton, R Winterhalder, RT Strebel, ... European urology 66 (3), 468-474, 2014 | 134 | 2014 |
| Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy M Decker, C Rothermundt, G Holländer, A Tichelli, C Rochlitz The lancet oncology 7 (8), 693-694, 2006 | 126 | 2006 |
| What is the role of routine follow-up for localised limb soft tissue sarcomas? A retrospective analysis of 174 patients C Rothermundt, JS Whelan, P Dileo, SJ Strauss, J Coleman, TW Briggs, ... British journal of cancer 110 (10), 2420-2426, 2014 | 99 | 2014 |
| Antiangiogenic drugs in oncology: a focus on drug safety and the elderly–a mini-review S Boehm, C Rothermundt, D Hess, M Joerger Gerontology 56 (3), 303-309, 2010 | 88 | 2010 |
| Management of von hippel-lindau disease: an interdisciplinary review S Schmid, S Gillessen, I Binet, M Brändle, D Engeler, J Greiner, C Hader, ... Oncology research and treatment 37 (12), 761-771, 2014 | 77 | 2014 |
| GeDDiS: a prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced … BM Seddon, J Whelan, SJ Strauss, MG Leahy, PJ Woll, F Cowie, ... Journal of Clinical Oncology 33 (15_suppl), 10500-10500, 2015 | 76 | 2015 |
| Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015 A Kollár, C Rothermundt, F Klenke, B Bode, D Baumhoer, V Arndt, ... Cancer epidemiology 63, 101596, 2019 | 56 | 2019 |
| Efficacy of cetuximab in metastatic castration-resistant prostate cancer might depend on EGFR and PTEN expression: results from a phase II trial (SAKK 08/07) R Cathomas, C Rothermundt, D Klingbiel, L Bubendorf, R Jaggi, ... Clinical cancer research 18 (21), 6049-6057, 2012 | 56 | 2012 |
| RANK ligand blockade with denosumab in combination with sorafenib in chemorefractory osteosarcoma: a possible step forward? R Cathomas, C Rothermundt, B Bode, B Fuchs, R Von Moos, M Schwitter Oncology 88 (4), 257-260, 2015 | 55 | 2015 |
| A pooled analysis of sequential therapies with sorafenib and sunitinib in metastatic renal cell carcinoma F Stenner, R Chastonay, H Liewen, SR Haile, R Cathomas, ... Oncology 82 (6), 333-340, 2012 | 48 | 2012 |
| Interdisciplinary evidence-based recommendations for the follow-up of testicular cancer patients: a joint effort R Cathomas, D Helbling, F Stenner, C Rothermundt, C Rentsch, O Shahin, ... Swiss medical weekly 140 (25-26), 356-369, 2010 | 44 | 2010 |
| Pre‐and postoperative chemotherapy in localized extremity soft tissue sarcoma: a European organization for research and treatment of cancer expert survey C Rothermundt, GF Fischer, S Bauer, JY Blay, V Grünwald, A Italiano, ... The oncologist 23 (4), 461-467, 2018 | 40 | 2018 |
| Analysis of side effect profile of alopecia, nail changes, peripheral neuropathy, and dysgeusia in prostate cancer patients treated with docetaxel and cabazitaxel A Omlin, O Sartor, C Rothermundt, R Cathomas, JS De Bono, L Shen, ... Clinical genitourinary cancer 13 (4), e205-e208, 2015 | 39 | 2015 |
| First-line treatment of metastatic clear cell renal cell carcinoma: a decision-making analysis among experts S Aeppli, M Schmaus, T Eisen, B Escudier, V Grünwald, J Larkin, ... ESMO open 6 (1), 100030, 2021 | 38 | 2021 |
| Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis CM Panje, M Glatzer, J von Rappard, C Rothermundt, T Hundsberger, ... BMC medical research methodology 17, 1-9, 2017 | 38 | 2017 |
| Choi response criteria for prediction of survival in patients with metastatic renal cell carcinoma treated with anti-angiogenic therapies N Schmidt, V Hess, T Zumbrunn, C Rothermundt, G Bongartz, S Potthast European radiology 23, 632-639, 2013 | 38 | 2013 |
